Pfizer (PFE) Receives a Hold from SVB Securities
SVB Securities analyst David Risinger maintained a Hold rating on
Pfizer (PFE – Research Report) on June 27 and set a price target of
$55.00. The company's shares closed last Wednesday at $50.94.
According to TipRanks.com, Risinger is a 2-star analyst with an
average return of 0.3% and a 33.3% success rate. Risinger covers
the Healthcare sector, focusing on stocks such as Vertex
Pharmaceuticals, Horizon Therapeutics, and Theravance Biopharma.
The word on The Street in general, suggests a Moderate Buy analyst
consensus rating for Pfizer with a $58.64 average price target,
representing a 15.6% upside.
から 7 2022 まで 8 2022
から 8 2021 まで 8 2022